UnitedHealth stock jumps after earnings top estimates despite rising medical costs

In this article

Representatives speak with customers at a UnitedHealthcare store in Queens, New York.
Michael Nagle | Bloomberg | Getty Images

UnitedHealth Group’s stock price jumped Friday after the health-care conglomerate reported second-quarter revenue and adjusted earnings that topped Wall Street’s expectations despite rising medical costs.

The results eased investor concerns after the Minnesota-based company flagged a surge in demand for non-urgent surgeries and outpatient services last month and spooked the market.

UnitedHealth Group is the biggest health-care company in the U.S. by market cap and revenue, and is even bigger than the nation’s largest banks. Given its size, UnitedHealth Group is considered a bellwether for the broader health insurance sector. Its market value was around $447 billion as of Friday afternoon.

Here’s what UnitedHealth Group reported compared with Wall Street’s expectations, based on a survey of analysts by Refinitiv:

  • Earnings per share: $6.14 adjusted vs. $5.99 expected 
  • Revenue: $92.9 billion vs. $91.01 billion expected

UnitedHealth Group reported a net income of $5.47 billion, or $5.82 per share, for the quarter. That compares with $5.07 billion, or $5.34 per share, for the same period a year ago. Excluding certain items, the company’s adjusted earnings per share were $6.14 for the period. 

The company reported total revenue of $92.9 billion for the quarter, up 16% from the same period a year ago. That excludes $33.6 billion in “eliminations,” which are payments from the company’s UnitedHealthcare business to its other division, Optum. UnitedHealth Group can’t record those transactions as revenue because it is paying itself.

UnitedHealthcare, which provides insurance coverage and benefits services to more than 50 million people, saw second-quarter revenue grow 13% from a year ago to $70.2 billion. 

The company’s other platform, Optum, saw revenue increase nearly 25% from a year ago to $56.3 billion, helped in part by UnitedHealth Group’s roughly $8 billion acquisition of the health care technology company Change Healthcare.

Optum offers health services and runs one of the largest pharmacy benefit managers, or middlemen who negotiate drug discounts with drug manufacturers on behalf of health insurers and large employers.

UnitedHealth Group raised the low end of its full-year adjusted earnings outlook to $24.70 to $25.00 per share, from a previous forecast of $24.50 to $25.00 per share. 

The company’s medical cost ratio – the percentage of payout on claims compared with premiums – came in at 83.2%. Analysts had estimated that ratio would be 83.3% for the quarter, according to FactSet. 

The medical cost ratio is up almost 2% from the same period a year ago. UnitedHealth Care said that was driven by the previously noted uptick in elective surgeries and outpatient care activity, primarily among seniors. 

Last month, UnitedHealth Group CFO John Rex said at the Goldman Sachs health-care conference that the company recorded “strong outpatient care activity” throughout April, May and early June. 

Most of that care has come from Medicare enrollees who are getting heart procedures and hip and knee replacements at outpatient clinics, according to Rex. 

Insurance companies have benefited in recent years from a delay in nonurgent procedures due to hospital staffing shortages and the pandemic, which saw hospitals inundated with Covid patients. Hospitals at that time were widely seen as too risky to enter for elective procedures.

But UnitedHealth Group executives indicated that the trend may be reversing.

Finance

Articles You May Like

Silver likely to touch Rs 1,25,000 over next few months: Motilal Oswal
NZDUSD reaches target resistance and backs off to 200 bar MA on 4-hour chart
Samsung shares hit over 3-year high after better-than-expected guidance on strong AI demand
The 2-10 year yield rises to -27.3 basis points. A close here will be highest since Jan 29
We are upgrading our rating on Wells Fargo as investors dump stock post-earnings

Leave a Reply

Your email address will not be published. Required fields are marked *